Jiangchuan Sun

Feb 3, 2024 | bmccancer.biomedcentral.com | Linlin Xiao |Xu Dong |Jiangchuan Sun |Xuerui Zhang |Qing Feng |Shufang Chang

MethodsThis was a retrospective cohort study of women (< 40 years old) with biopsy-confirmed HSILs who were treated with either FUS or LEEP at the Second Affiliated Hospital of Chongqing Medical University from September 1, 2020 to May 31, 2022. All patients consented to the review of their medical records according to the ethical approval guidelines (Ethics Committee of the hospital reference NO. 2022170).